
Biotechnology • Pharmaceuticals • Healthcare Insurance
Iovance Biotherapeutics, Inc. is pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and attack diverse cancer cells in each patient. The company focuses on T-cell-based immunotherapy, specifically Tumor Infiltrating Lymphocyte (TIL) therapy, which involves reinvigorating a patient’s TILs to fight cancer. Iovance's TIL therapy is being investigated in clinical trials across multiple advanced solid tumor cancers. Additionally, the company is advancing genetically modified TIL therapies and exploring potential applications of PBL (peripheral blood lymphocyte) therapy for blood cancers. As a leader in cell therapy, Iovance owns a state-of-the-art Cell Therapy Center in Philadelphia for manufacturing their therapies using proprietary GMP. The company is at the forefront of developing personalized and patient-specific cancer treatments.
November 25
Senior Vice President managing global accounting team for Iovance Biotherapeutics. Overseeing accounting policies and ensuring compliance with financial regulations.
November 20
Computer Systems Validation Analyst ensuring compliance with regulations through effective documentation. Supporting the validation lifecycle for computer systems in a biotherapeutics environment.
October 31
Case Manager with Iovance Biotherapeutics managing patient cases and collaborating with healthcare providers in the cell therapy industry.
September 24
Project Manager coordinating timelines, contracts, and deliverables for Process and Analytical Development at Iovance Biotherapeutics. Drives project plans, processes, and cross-functional collaboration.
September 24
Lead global CMC regulatory strategy and submissions for cell and gene therapies at Iovance Biotherapeutics, ensuring compliance and cross-functional alignment.